Friday, 22 September 2017

Ayurvedic management of diabetes

05 June 2017 | News

BGR-34 is the first and the only Ayurvedic medicine, which has got into the club of top 20 anti-diabetic Allopathic drugs.

BGR-34 is the first and the only Ayurvedic medicine, which has got into the club of top 20 anti-diabetic Allopathic drugs. Its efficacy in keeping a check over diabetes has been found a spiraling 67% during clinical trials.

Anti-diabetic Ayurvedic drug BGR-34, developed by the Council of Scientific and Industrial Research (CSIR) – the research wing of the Science & Technology Ministry, has found a place among the 20 top branded drugs manufactured by multinational Pharma Companies. This news was revealed by a survey conducted by the All Indian Origin Chemists and Distributors (AIOCD).

Competing with the allopathic medicine of multinational companies such as Sanofi, Zydus and Lupin, the BGR-34,has been jointly developed by the two laboratories of CSIR, National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plant (CIMAP).

The drug having 6 vital phyto-constituent extracts and derivatives makes it promising, safe and effective to help maintain normal glucose levels and reducing the chances of long term complications.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Does primary healthcare in India needs prioritization?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls